Biochemical coupling of transcription factor NF-kB to antigen and co-stimulatory receptors is required for the temporal control of T-cell proliferation. In contrast to its transitory activation during normal growth-signal transduction, NF-kB is constitutively deployed in T-cells transformed by the type 1 human T-cell leukemia virus (HTLV-1). This viral/host interaction is mediated by the HTLV-1-encoded Tax protein, which has potent oncogenic properties. As reviewed here, Tax activates NF-kB primarily via a pathway leading to the chronic phosphorylation and degradation of IkBa, a cytoplasmic inhibitor of NF-kB. To access this pathway, Tax associates stably with a cytokine-inducible IkB kinase (IKK), which contains both catalytic (IKKa and IKKb) and noncatalytic (IKKg) subunits. Unlike their transiently induced counterparts in cytokine-treated cells, Taxassociated forms of IKKa and IKKb are persistently activated in HTLV-1-infected T cells. Acquisition of the deregulated IKK phenotype is contingent on the presence of IKKg, which functions as a molecular adaptor in the assembly of pathologic Tax/IkB kinase complexes. These ®ndings highlight a key mechanistic role for IKK in the Tax/NF-kB signaling axis and de®ne new intracellular targets for the therapeutic control of HTLV-1-associated disease.